{"id":988965,"date":"2026-08-03T23:08:07","date_gmt":"2026-08-04T03:08:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/"},"modified":"2026-08-03T23:08:07","modified_gmt":"2026-08-04T03:08:07","slug":"klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/","title":{"rendered":"KLRS:  Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">STAMFORD, Conn., Aug.  03, 2026  (GLOBE NEWSWIRE) &#8212; Abbott Cooper PLLC is investigating potential legal claims on behalf of stockholders of Kalaris Therapeutics, Inc. (Nasdaq: KLRS), formerly AlloVir, Inc. (Nasdaq: ALVR), who have continuously held their shares since prior to November 7, 2024.<\/p>\n<p align=\"left\">This investigation concerns whether the members of the board of directors of Kalaris Therapeutics, Inc., then known as AlloVir, Inc., breached their fiduciary duties.<\/p>\n<p align=\"left\">Stockholders who have continuously held Kalaris Therapeutics, Inc. shares since prior to November 7, 2024, and are interested in learning more about the investigation or their legal rights, are encouraged to contact Abbott Cooper PLLC at no cost or obligation.<\/p>\n<p align=\"left\">Abbott Cooper PLLC handles cases on a contingency fee basis, meaning there is no cost to stockholders unless a recovery is obtained.<\/p>\n<p align=\"left\">IF YOU ARE A KALARIS THERAPEUTICS, INC. (FORMERLY ALLOVIR, INC.) STOCKHOLDER AND WOULD LIKE TO DISCUSS YOUR LEGAL RIGHTS, PLEASE CONTACT:<\/p>\n<p align=\"left\">J. Abbott R. Cooper<br \/>Abbott Cooper PLLC<br \/>1266 East Main Street<br \/>Suite 700R<br \/>Stamford, CT 06902<br \/>(475) 477-5031<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YV9PdmPOoHgckMshpeGqezNC9X7V9WtNpc3hJgaazr5NQOMgrEse0CIVJkNd5JtuxutRmBs98kjXKK-Fs5MIaU6wcpMsVTN-LI-D4KeufTU=\" rel=\"nofollow\" target=\"_blank\">info@abbottlawyer.com<\/a><br \/>https:\/\/abbottlawyer.com\/<\/p>\n<p align=\"left\">Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMjg3NyM3NzU2NDAwIzIyNjM0MTE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YmU4MDAwODgtN2NlYy00ZDlmLTk1MzEtYWIzNGVhN2UyOGUxLTEyNzQ5NjEtMjAyNi0wOC0wNC1lbg==\/tiny\/Abbott-Cooper-PLLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>STAMFORD, Conn., Aug. 03, 2026 (GLOBE NEWSWIRE) &#8212; Abbott Cooper PLLC is investigating potential legal claims on behalf of stockholders of Kalaris Therapeutics, Inc. (Nasdaq: KLRS), formerly AlloVir, Inc. (Nasdaq: ALVR), who have continuously held their shares since prior to November 7, 2024. This investigation concerns whether the members of the board of directors of Kalaris Therapeutics, Inc., then known as AlloVir, Inc., breached their fiduciary duties. Stockholders who have continuously held Kalaris Therapeutics, Inc. shares since prior to November 7, 2024, and are interested in learning more about the investigation or their legal rights, are encouraged to contact Abbott Cooper PLLC at no cost or obligation. Abbott Cooper PLLC handles cases on a contingency fee basis, meaning there is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;KLRS:  Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-988965","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"STAMFORD, Conn., Aug. 03, 2026 (GLOBE NEWSWIRE) &#8212; Abbott Cooper PLLC is investigating potential legal claims on behalf of stockholders of Kalaris Therapeutics, Inc. (Nasdaq: KLRS), formerly AlloVir, Inc. (Nasdaq: ALVR), who have continuously held their shares since prior to November 7, 2024. This investigation concerns whether the members of the board of directors of Kalaris Therapeutics, Inc., then known as AlloVir, Inc., breached their fiduciary duties. Stockholders who have continuously held Kalaris Therapeutics, Inc. shares since prior to November 7, 2024, and are interested in learning more about the investigation or their legal rights, are encouraged to contact Abbott Cooper PLLC at no cost or obligation. Abbott Cooper PLLC handles cases on a contingency fee basis, meaning there is &hellip; Continue reading &quot;KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-04T03:08:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMjg3NyM3NzU2NDAwIzIyNjM0MTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders\",\"datePublished\":\"2026-08-04T03:08:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\\\/\"},\"wordCount\":188,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMjg3NyM3NzU2NDAwIzIyNjM0MTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\\\/\",\"name\":\"KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMjg3NyM3NzU2NDAwIzIyNjM0MTE=\",\"datePublished\":\"2026-08-04T03:08:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMjg3NyM3NzU2NDAwIzIyNjM0MTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgwMjg3NyM3NzU2NDAwIzIyNjM0MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/","og_locale":"en_US","og_type":"article","og_title":"KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders - Market Newsdesk","og_description":"STAMFORD, Conn., Aug. 03, 2026 (GLOBE NEWSWIRE) &#8212; Abbott Cooper PLLC is investigating potential legal claims on behalf of stockholders of Kalaris Therapeutics, Inc. (Nasdaq: KLRS), formerly AlloVir, Inc. (Nasdaq: ALVR), who have continuously held their shares since prior to November 7, 2024. This investigation concerns whether the members of the board of directors of Kalaris Therapeutics, Inc., then known as AlloVir, Inc., breached their fiduciary duties. Stockholders who have continuously held Kalaris Therapeutics, Inc. shares since prior to November 7, 2024, and are interested in learning more about the investigation or their legal rights, are encouraged to contact Abbott Cooper PLLC at no cost or obligation. Abbott Cooper PLLC handles cases on a contingency fee basis, meaning there is &hellip; Continue reading \"KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-04T03:08:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMjg3NyM3NzU2NDAwIzIyNjM0MTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders","datePublished":"2026-08-04T03:08:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/"},"wordCount":188,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMjg3NyM3NzU2NDAwIzIyNjM0MTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/","name":"KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMjg3NyM3NzU2NDAwIzIyNjM0MTE=","datePublished":"2026-08-04T03:08:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMjg3NyM3NzU2NDAwIzIyNjM0MTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgwMjg3NyM3NzU2NDAwIzIyNjM0MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/klrs-abbott-cooper-pllc-announces-investigation-on-behalf-of-kalaris-therapeutics-inc-formerly-allovir-inc-stockholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/988965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=988965"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/988965\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=988965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=988965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=988965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}